MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/medsci14020328

Медицинская библиотека · Medical sciences (Basel, Switzerland) · 2026

Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Anemia in Patients with Chronic Kidney Disease: A Pre-Post Observational Analysis.

Gajić Selena, Simović Filip, Bontić Ana, Kezić Aleksandra, Stojadinović Milorad, Mijušković Svetozar, Pavlović Jelena, Ristanović Vidna Karadžić, Popović Verica Stanković, Vićentijević Dušan, Bjeličić Milija, Petrović Kristina, Mrđa Ivana, Filić Kristina, Shawamri Saddam, Stanković Sanja, Baralić Marko

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

Background and

Objectives

Anemia is a common complication of chronic kidney disease (CKD) and is associated with reduced quality of life, accelerated disease progression, and increased cardiovascular risk. Sodium-glucose cotransporter-2 inhibitors (SGLT2is) have demonstrated significant renal and cardiovascular benefits, and clinical trials have reported improvements in hematologic parameters during treatment. However, real-world evidence regarding their longitudinal effects on hemoglobin (Hb) and iron metabolism in patients with CKD remains limited. Materials and

Methods

We conducted a pre-post analysis of 118 adult patients with CKD stages 1-4 treated with SGLT2is (empagliflozin or dapagliflozin) at the University Clinical Center of Serbia between January 2024 and June 2025. Patients received either agent at 10 mg once daily for 18 months. Hb, ferritin, C-reactive protein (CRP), albumin (Alb), daily proteinuria (Prt), and estimated glomerular filtration rate (eGFR) were assessed at baseline and at 18 months. Ferritin was adjusted for inflammatory and nutritional status using a residualization model incorporating CRP and Alb. Changes between the two time points were analyzed using repeated-measures general linear models (GLMs).

Results

In unadjusted analyses, mean Hb increased modestly from 136.5 ± 17.9 g/L at baseline to 138.8 ± 18.9 g/L at follow-up (p = 0.028), while median ferritin decreased from 102.2 µg/L to 89.9 µg/L (p = 0.011). After adjustment for CRP and Alb, ferritin levels remained unchanged (p = 0.752). Repeated-measures analyses showed no significant longitudinal effect of time on Hb or ferritin and no significant interaction between time and SGLT2i type. Baseline eGFR, Prt, sex, and baseline ferritin significantly influenced longitudinal hematologic trajectories.

Conclusions

SGLT2i therapy was associated with modest increases in Hb levels over 18 months, while inflammatory status remained stable and no significant reduction in ferritin levels was observed after adjustment for inflammatory and nutritional factors. Longitudinal Hb and ferritin trajectories did not differ significantly between empagliflozin and dapagliflozin, while baseline kidney function, Prt, iron status, and sex significantly influenced hematologic outcomes. Although causal inference is limited by the absence of a control group, these findings suggest a possible favorable effect of SGLT2is on anemia-related parameters in patients with CKD.

Для цитирования: Gajić Selena, Simović Filip, Bontić Ana, Kezić Aleksandra, Stojadinović Milorad, Mijušković Svetozar, Pavlović Jelena, Ristanović Vidna Karadžić, Popović Verica Stanković, Vićentijević Dušan, Bjeličić Milija, Petrović Kristina, Mrđa Ivana, Filić Kristina, Shawamri Saddam, Stanković Sanja, Baralić Marko. Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Anemia in Patients with Chronic Kidney Disease: A Pre-Post Observational Analysis.. Medical sciences (Basel, Switzerland). 2026. DOI: 10.3390/medsci14020328.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.